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Background: Chronic knee pain is a common and disabling condition in people over 50 years of age, with knee
joint osteoarthritis being a major cause. Acupuncture is a popular form of complementary and alternative medicine
for treating pain and dysfunction associated with musculoskeletal conditions. This pragmatic Zelen-design
randomised controlled trial is investigating the efficacy and cost-effectiveness of needle and laser acupuncture,
administered by medical practitioners, in people with chronic knee pain.
Methods/Design: Two hundred and eighty two people aged over 50 years with chronic knee pain have been
recruited from metropolitan Melbourne and regional Victoria, Australia. Participants originally consented to
participate in a longitudinal natural history study but were then covertly randomised into one of four treatment
groups. One group continued as originally consented (ie natural history group) and received no acupuncture
treatment. The other three were treatment groups: i) laser acupuncture, ii) sham laser or, iii) needle acupuncture.
Acupuncture treatments used a combined Western and Traditional Chinese Medicine style, were delivered by
general practitioners and comprised 8–12 visits over 12 weeks. Follow-up is currently ongoing. The primary
outcomes are pain measured by an 11-point numeric rating scale (NRS) and self-reported physical function
measured by the Western Ontario and McMaster (WOMAC) Universities Osteoarthritis Index subscale at the
completion of treatment at 12 weeks. Secondary outcomes include quality of life, global rating of change scores
and additional measures of pain (other NRS and WOMAC subscale) and physical function (NRS). Additional
parameters include a range of psychosocial measures in order to evaluate potential relationships with acupuncture
treatment outcomes. Relative cost-effectiveness will be determined from health service usage and outcome data.
Follow-up assessments will also occur at 12 months.
Discussion: The findings from this study will help determine whether laser and/or needle acupuncture is
efficacious, and cost-effective, in the management of chronic knee pain in older people.
Trial registration: Australian New Zealand Clinical Trials Registry reference: ACTRN12609001001280Background
Chronic knee pain is a common and disabling condition,
particularly in people over 50 years of age [1,2]. Knee
joint osteoarthritis (OA) is a major cause of knee pain
and results in loss of functional independence, psycho-
logical impairment and a reduction in the overall* Correspondence: ranash@unimelb.edu.au
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reproduction in any medium, provided the orquality-of-life of affected individuals. In addition to the
personal burden of knee OA, there are substantial direct
and indirect health care costs particularly in terms of
employment status, productivity and joint replacement
surgery, making knee OA a substantial public health
problem.
Management of knee OA is primarily focused on treat-
ing the pain and disability associated with the condition,
with non-pharmacological therapies considered the
cornerstone of treatment [3]. Acupuncture is a popular
treatment for pain and dysfunction associated withl Ltd. This is an Open Access article distributed under the terms of the Creative
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ogy patients in the United Kingdom revealed that 61% of
those with OA had used acupuncture [4]. In clinical
practice, a range of health professionals administer or
refer patients for acupuncture. In Australia, acupuncture
by medical practitioners has been established for 40 years
and has gained widespread patient acceptance in the
community. We have found that over 80% of surveyed
general medical practitioners referred patients for acu-
puncture [5] and that they generally consider acupunc-
ture to be highly effective and safe [6]. Amongst all
complementary and alternative medicine modalities,
acupuncture is associated with the highest average
annualised expenditure [7]. Thus research to determine
its efficacy and cost-effectiveness is warranted.
Acupuncture traditionally involves the insertion of fine
needles into specific points of the body. According to
the ancient philosophy of traditional Chinese acupunc-
ture, energy circulates in 12’meridians’ located through-
out the body. Pain or ill health will result if the meridian
energy circulation is blocked. Stimulating the appropri-
ate combination of meridian acupuncture points in the
body can restore energy circulation, health, and balance
[8]. From a Western medicine perspective, acupuncture
is a technique of peripheral sensory stimulation (through
activation of peripheral A-delta and C fibres) applied at
acupuncture points and/or trigger points that can acti-
vate central nervous system pain pathways, release spe-
cific pain relieving substances as well as reduce muscle
and sympathetic nervous system tonicity [9,10].
In recent years there has been a substantial increase in
the number of randomised controlled trials (RCTs) in-
vestigating the efficacy of needle acupuncture for
chronic knee pain. A recent meta-analysis concluded
that while placebo-controlled trials show statistically sig-
nificant benefits for pain, the benefits are small and un-
likely to be clinically relevant [8]. Waiting list-controlled
trials however suggest statistically significant and clinic-
ally relevant benefits, which may be due to expectation
or placebo effects. Accordingly, well-designed rigorous
RCTs are needed that control for both placebo and ex-
pectation effects in order to evaluate the efficacy of acu-
puncture for chronic knee pain.
Although acupuncture has been traditionally adminis-
tered with needles, the use of laser acupuncture has
increased because of its pain-free nature and minimal
adverse effects [11]. Laser acupuncture involves the ap-
plication of low-level laser, which is a form of electro-
magnetic radiation in the visible or infrared region of
the light spectrum. These laser devices are manufactured
with such low energy densities that photo-chemical
changes are elicited without photo-thermal effects.
Within these ranges, various energy levels and wave-
lengths can be used depending on the tissue penetrationrequired. In laser acupuncture, the beam of light gener-
ated is applied to the skin at acupuncture points and/or
trigger points, similar to the application of needles.
Laser acupuncture effects are thought to alter periph-
eral afferent nerve stimulation, modulating spinal cord
afferent input on second order neurons and enhancing
peripheral endogenous opioid analgesia [12] as well as
acting via centrally mediated mechanisms. Laser also has
effects at the local cellular and tissue level [13] with evi-
dence of modulation of inflammatory processes [14]
varying according to laser dosage [15].
In contrast to needle acupuncture, the efficacy of laser
acupuncture has been less well studied in the manage-
ment of chronic knee pain. In general, RCTs have used
small sample sizes and variable laser dosages in terms of
wavelength, total energy, application sites and number of
treatments. In a meta-analysis of eight trials published
up until 2006 investigating the short-term efficacy
(within 4 weeks) of laser therapy for knee OA, statisti-
cally and potentially clinically significant pain-relieving
benefits over placebo were found [11]. The effect was
greater when only trials evaluating an optimal dosage
and administration were included. Since this meta-
analysis, two other small studies have been published
providing further support for the use of laser acu-
puncture in chronic knee pain [16,17].
It is not clear whether differences in efficacy exist be-
tween laser and needle acupuncture given that there are
no direct head-to-head comparisons of needle and laser
acupuncture for chronic knee pain., However, in a sys-
tematic review, laser but not needle acupuncture offered
statistically and clinically significant short-term pain re-
lief over placebo [11]. Similarly, a meta-analysis found
that treatment with laser acupuncture had better pain
outcomes in the medium-term, although not short-term,
than treatment with needle acupuncture in people with
non-specific neck pain [18]. These studies suggest that
laser acupuncture may be at least as effective, if not
more effective, than needle acupuncture.
It is apparent that there is a need for further evalu-
ation of acupuncture in the management of chronic
knee pain. This is highlighted by discrepancies in recom-
mendations by clinical guidelines – the Osteoarthritis
Research Society International currently recommend
acupuncture [3], the United Kingdom NICE clinical
guidelines could not give a firm recommendation due to
insufficient evidence [19] and the American College of
Rheumatology [20] conditionally recommend acupunc-
ture but only for patients with moderate to severe pain
who are candidates for joint replacement but are unwill-
ing/unable to have surgery. Furthermore, there is limited
information about the maintenance of acupuncture
effects with no studies reporting a follow-up longer than
three months.
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logical concern in acupuncture trials has been the
difficulty in having a true placebo control group given
pre-existing participant expectations, particularly where
the treatment itself is multidimensional involving
therapist-patient interaction as well as an intervention
[21]. A meta-analysis has confirmed a significant placebo
effect for the treatment of pain in knee OA that varies in
size depending on the intervention [22]. For acupunc-
ture, the placebo effect size (mean 0.71 (95% confidence
interval 0.53, 0.90)) was higher than the overall effect
size for all placebo treatments (0.51 (0.46, 0.55)). As with
many treatments, higher patient expectation has been
shown to be associated with greater improvements fol-
lowing acupuncture treatment. A pooled analysis of four
clinical trials of acupuncture found that after completion
of treatment, the odds ratio for response between
patients considering acupuncture an effective or highly
effective therapy and patients who were more sceptical
was 1.67 (95% confidence interval 1.20-2.32) [23]. The
use of “sham needle” acupuncture as a placebo control,
whereby needling is performed superficially or at non-
acupuncture sites, is controversial given that such a pro-
cedure may still produce biological responses and hence
may not be truly placebo. Blinding of clinicians adminis-
tering needle acupuncture is also problematic. Such
methodological difficulties can be overcome in trials of
laser acupuncture as it is possible to successfully blind
both participants and clinicians by using specially
designed laser machines [24].
First described by Zelen in the New England Journal
of Medicine in 1979 [25], Zelen design trials are a means
of reducing bias by minimizing participant expectations
in a treatment trial where the knowledge of the interven-
tion itself may influence the study outcome (Hawthorne
effect) in the control group. This is done by enrolling
participants into an observational study but covertly ran-
domising participants following their recruitment into a
treatment trial (post-randomised consent). The control
group remains unaware of the treatment being evaluated
[26]. Such a design has been used successfully in a study
comparing a physiotherapy treatment of exercise and
knee taping to standard non-physiotherapy treatment in
people with predominant patellofemoral OA [27]. A po-
tential disadvantage of the Zelen design can be a higher
crossover rate than a usual RCT which may dilute treat-
ment effects in an intention-to-treat analysis. However, a
review of 58 RCTs using the Zelen design found that
while most trials (n = 41) experienced some crossover
from one group to the other (median crossover = 8.9%,
interquartile range 2.6% to 15%) the rate was usually
within acceptable limits [26].
Thus, we are currently conducting a Zelen design
RCT to investigate the efficacy of needle and laseracupuncture administered by experienced medical acu-
puncturists in people with chronic knee pain and to
evaluate maintenance of effects over the longer term.
We will also evaluate the cost-effectiveness of needle
and laser acupuncture, as well as explore whether psy-
chosocial measures are associated with changes in pain,
physical function and health-related quality of life fol-
lowing acupuncture treatment. This paper describes the
protocol for this ongoing trial.
The primary hypotheses are that:
H1: Laser acupuncture will result in significantly
greater improvements in pain (as measured overall
via numerical rating scale (NRS)) and physical
function (as measured via Western Ontario and
McMaster (WOMAC) Universities Osteoarthritis
Index) than sham laser acupuncture at 12 weeks.
H2: Laser and needle acupuncture will result in
significantly greater improvements in pain (as
measured overall via NRS and physical function
(as measured via WOMAC) than no treatment at
12 weeks.
H3: Laser acupuncture will result in significantly
greater improvements in pain (as measured overall
via NRS) and physical function (as measured via
WOMAC) than needle acupuncture at 12 weeks.
The secondary hypotheses are that:
H4: Sham laser acupuncture will result in significantly
greater improvements in pain (as measured overall
via NRS) and physical function (as measured via
WOMAC) than no treatment at 12 weeks.
H5: Laser, sham laser and needle acupuncture will
result in significantly greater improvements in pain
(as measured overall via NRS) and physical
function (as measured via WOMAC) than no
treatment at 12 months, while laser acupuncture
will result in significantly greater improvements
than needle acupuncture.
H6: Laser, sham laser and needle acupuncture will
result in significantly greater improvements in pain
(as measured on standing and walking via NRS
and by WOMAC), physical function (as measured
via NRS) and health-related quality of life than no
treatment at 12 weeks and 12 months.
H7: Laser acupuncture will result in significantly
greater improvements in pain (as measured on
standing and walking via NRS and by WOMAC),
physical function (as measured via NRS) and
health-related quality of life than needle
acupuncture at 12 weeks and 12 months.
H8: A greater proportion of people receiving laser,
sham laser and needle acupuncture will report
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treatment at 12 weeks and 12 months.
H9: A greater proportion of people receiving laser
acupuncture will report global overall
improvements compared to needle acupuncture at
12 weeks and 12 months.
Methods/Design
Trial design
A two-stage Zelen design RCT [25,28] which conforms
to CONSORT [29] and STRICTA guidelines [30] for
acupuncture studies (Figure 1).
Participants
A total of 282 men and women with chronic knee pain
have been recruited from the community in metropol-
itan Melbourne and regional Victoria, Australia. A num-
ber of recruitment strategies were used including (i)
advertisements in local clubs, community centres, news-
papers, Arthritis Australia and University websites, Uni-
versity staff newsletters, radio, television, and a social
networking site; (ii) placement of brochures and study
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Figure 1 Flow diagram of study protocol.presentations about knee OA in the local community by
the researchers.
People were eligible to participate if they (i) were aged
>50 years; (ii) had a history of knee pain of >3 months
duration; (iii) reported knee pain on most days of the
past month; (iv) reported an average knee pain severity
over the past month of ≥ 4 out of 10 on an 11-point NRS
and; (v) reported morning knee stiffness of <30 minutes
duration.
Exclusion criteria included: (i) history of any systemic
arthritic condition; (ii) history of knee arthroplasty on the
most painful knee; (iii) wait-listed for any knee surgery for
either knee; (iv) history of any knee surgery in previous
6 months; (v) any other condition affecting lower limb
function (eg trauma, malignancy, neurological condition);
(vi) history of any knee injection in past 6 months (eg cor-
tisone, hyaluronic acid); (vii) current use of oral or inject-
able anticoagulant medication; (viii) use of acupuncture in
past 12 months; (ix) any bleeding disorder; (x) allergy to
light; (xi) referral to pain clinic or use of morphine or
pethadine within past 6 months; (xii) any other medical
condition precluding participation in the trial (eg kidney
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written informed consent.
Although both knees could undergo treatment as part
of the project, only the most symptomatic knee as nomi-
nated by the participant at enrolment was evaluated.
Procedure
Figure 1 depicts the trial protocol. Eligibility of prospective
participants was determined over the telephone by an in-
vestigator (MK) not involved in assessment or treatment
of participants. Ethical approval was obtained from the
University of Melbourne Human Research Ethics Com-
mittee (HREC No. 0931840). All participants provided
written informed consent. Initially, all participants con-
sented to participate in a longitudinal observational nat-
ural history study of chronic knee pain, involving
assessments at baseline, 12 weeks and 12 months. All
assessments, comprised solely of questionnaires, are com-
pleted by participants at home and mailed back to the
University of Melbourne, where data is entered by a
blinded assessor (MK).
Upon receipt of completed baseline questionnaires, an
investigator (KN) accessed the computerised covert ran-
domisation schedule to reveal whether the participant
was allocated either (i) laser acupuncture (could be ei-
ther real laser or sham laser but the investigator and
participant are blinded to this information); (ii) needle
acupuncture or; (iii) no treatment (control group). Parti-
cipants randomised into the no treatment arm continue
as consented in the natural history observational cohort
for the 12 month duration of the study and did not
undergo (or are made aware of ) any intervention as part
of the trial. Participants randomised to receive either
laser or needle acupuncture were telephoned by an in-
vestigator (KN) and offered the opportunity to undergo
the allocated intervention and contribute their data to
the trial. Participants allocated to the laser groups were
informed they may receive either real laser or sham laser
and that this has been randomly pre-determined and
would not be revealed to them until the completion of
the 12 month assessments. Participants willing to par-
ticipate in the intervention provided informed consent
to do so at this point. Participants who choose not to
participate in the intervention continued as initially con-
sented in the natural history observational cohort for
12 months, however their data will be analysed as per
intention-to-treat.
Participants who were randomised to receive acupunc-
ture had treatment visits arranged with a project general
practitioner (GP) for treatment over 12 weeks. All study
participants, including those allocated to the no treat-
ment group and those who were randomised to receive
treatment but declined to do so, undergo re-assessment
at 12 weeks and again at 12 months.Randomisation and allocation concealment
The randomisation schedule was prepared by the study
biostatistician (AF). All eligible participants were consecu-
tively randomised into either the (i) real laser acupuncture;
(ii) sham laser acupuncture; (iii) needle acupuncture or;
(iv) no treatment group. Allocation was randomised
within random permuted blocks of six to twelve generated
a priori and stratified according to treating GP so that all
GPs delivered approximately equal numbers in each acu-
puncture group to control for therapist variation. An elec-
tronic password-protected spreadsheet that contained
concealed acupuncture group allocation was prepared by
a researcher (BM) with no other involvement in the study,
and held by an investigator (MP) not involved in recruit-
ment, assessment or treatment. The patient code numbers
for the randomised laser treatment arms were entered into
the study laser machines by an independent biomedical
engineer, in order to permit blinding of both the treating
GPs and the participants.
Blinding
Laser and sham laser participants were blinded to treat-
ment allocation, as were the GPs administering laser and
sham laser acupuncture, as the same machine provided
both interventions and the participant code (entered by
the GP) determined whether the machine actually out-
putted laser or not [24]. Participants in the no treatment
group are unaware that the treatment groups exist and
that their data will be used for comparison (despite hav-
ing consented to their longitudinal data being used for
other unspecified research questions as determined by
the researchers). Only the participants undergoing nee-
dle acupuncture and the GP provider were unblinded to
their treatment group allocation.
Interventions
This trial employed a combined Western and Traditional
Chinese Medicine style of acupuncture, utilizing standar-
dised acupuncture points. Such an approach reflects Aus-
tralian medical acupuncture training and clinical practice.
Participants were treated by experienced GPs who are also
members of the Australian Medical Acupuncture College.
These GPs have completed a standardised University-
delivered acupuncture training course, undertaken formal
accreditation by examination and a minimum period of
supervised clinical experience, and are registered as med-
ical practitioner acupuncturists by the Medical Board of
Victoria. Medical acupuncturists were selected for this
study to minimise potential confounder effects related to
using health practitioners with varying qualifications, clin-
ical experience and expertise. A total of 8 GPs in 9 loca-
tions around metropolitan Melbourne and regional
Victoria were involved (Table 1). The GPs had an average
of 33.3 years of clinical practice and 19.6 years of medical
Table 1 Descriptive characteristics of the general
practitioners who provided acupuncture treatment
General
practitioner











2 Male Anglesea 30 24
3 Male Wendouree 48 30
4 Female Glen Waverley 25 18
5 Male Mildura 20 10
6 Male Traralgon 25 12
7 Male Malvern 50 19
8 Male Bendigo 45 30
Table 2 Framework of acupuncture points that could be
selected by general practitioners when administering
acupuncture treatments (laser and needles)
Location Acupuncture points
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puncture experience.
The GPs attended a four-hour training session run by
an investigator (IR) who is an experienced medical acu-
puncturist, to standardise all aspects of the treatment
protocol. This same investigator maintained regular con-
tact with the GPs throughout the trial to answer any
treatment-related questions and ensure compliance. Each
GP was provided with a detailed treatment manual de-
scribing administration of the acupuncture interventions
as well as the trial protocol. GPs were supplied with a pre-
coded laser machine (custom-designed to deliver both real
and sham laser) and standardized needles required for
administering the acupuncture interventions.
Acupuncture treatments (approximately 20 minutes in
duration) were administered once or twice weekly (at
the GP’s discretion) in the GP’s rooms for 12 weeks, with
a minimum of 8 and a maximum of 12 treatments deliv-
ered. Participants did not pay for treatment and the
treating GPs were reimbursed for their time on a per pa-
tient basis.
The treatment protocol permitted the GPs to treat
participants as they would treat patients in their normal
practice. They were allowed to select from a standar-
dized set of acupuncture points around the knee, as well
as distal points on the intervention side (Table 2). Other
points could be used at the GP’s discretion depending
on the cause(s) and site of the pain evident at clinical
examination. These included points indicated by Trad-
itional Chinese Medicine diagnoses in relation to Zang-
Fu organ dysfunction, associated meridian and deep
channel connections and ear points. Because of varying
participant sensitivity, the initial treatment session per-
mitted a maximum of six points in total, including four
points on the study limb and two other points chosen as
per protocol. In subsequent treatment sessions, furtherpoints were added as clinically indicated by participant
response to treatment, as well as local tenderness,
muscle tightness and/or swelling. Over subsequent treat-
ments, acupuncture points were varied according to
changes in participant symptoms and point reactivity.
The 12-week treatment period allowed for patient at-
tendance flexibility (a break of up to four weeks between
visits was deemed acceptable for participants going away
on holidays etc.), as well as for strong acupuncture
responders to have several days settling time as neces-
sary. Visits were scheduled twice per week if necessary,
but weekly visits were generally recommended. Treat-
ment was considered complete when pain and function
had returned to normal, however a minimum of 8 treat-
ments was required. Laser acupuncture interventions
were administered with the patient positioned either su-
pine or sitting over the edge of the treatment couch.
Treating GPs completed standardized treatment notes
after each acupuncture session. Information recorded
included the acupuncture points treated and any adverse
events reported by the patient from the previous session.
Needle acupuncture
Patients randomised to the needle acupuncture treat-
ment underwent treatment lying down with needles
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Sierin needles (0.25x40mm) were used. The needles were
inserted and left in place with the participant to rest.
Needles were disposed of into a bedside sharps container
at the completion of treatment.
Laser and placebo laser acupuncture
Laser acupuncture was administered at the selected
acupuncture points using a Acupak P/L (Melbourne)
laser machine that was specially manufactured for use
in this trial [24]. The laser machines were standard
Class 3B laser devices that are licensed by the Austra-
lian Therapeutic Goods Association with an output of
10 mW. Energy output was 0.2 J per acupuncture point.
Laser strength was checked by the manufacturer (a bio-
medical engineer) at study commencement, halfway
through the study and will be repeated at study com-
pletion. Laser strength testing is a routine procedure in
laser manufacture and maintenance and is done with a
standard laser testing device. The trial laser machine
had a small red non-laser light source arising from in-
side the probe tip that lit up when the probe was in
both treatment mode and sham mode (no output). This
acted as a decoy to the treatment beam, which is invis-
ible. Therefore, neither the treating GP nor the partici-
pant could detect any difference between the real orTable 3 Summary of measures collected as part of the study
Primary outcome measures
Average overall pain in past week
Physical function in past 48 hours
Secondary outcome measures
Average pain on i) walking and ii) standing in past week
Pain over past 48 hours
Average restriction to daily activity in past week
Participant global rating of change in i) pain ii) physical function
and iii) overall.




Use of health care/home assistance and work absences
Adverse events
Treatment session attendance
All measures are recorded at baseline, 12 weeks and 12 months unless otherwise stsham laser treatment being applied. The trial laser
machines were programmed by the manufacturer. At
each treatment session, the GP typed the participant’s
study code into the keypad of the machine, and the ma-
chine automatically delivered either laser acupuncture
(ie laser output) or sham laser acupuncture (ie no laser
output) according to the programmed randomisation
schedule.
Outcome measures
Table 3 summarises the range of measures that are being
collected as part of this study. The majority of outcomes
are measured at baseline, 12 weeks and 12 months in all
participants (irrespective of group allocation). All out-
comes are collected via self-report questionnaire and
mailed back to the investigators.
Age, gender, height, weight, duration and nature (uni-
lateral/bilateral) of knee symptoms and previous treat-
ment for knee joint problems were obtained by
questionnaire at baseline for descriptive purposes.
Self-reported pain and physical function
The primary pain outcome is average overall knee pain
over the past week. This is assessed using an 11-point
NRS with terminal descriptors of “no pain” and “worst
pain possible”. Similar scales are also being used toData collection instrument
11-point numerical rating scale (NRS)
Western Ontario McMaster Universities (WOMAC)
Osteoarthritis Index 3.1 Likert version
11-point NRS
WOMAC Osteoarthritis Index 3.1 Likert version
11-point NRS
5-point ordinal scales (12 weeks and 12 months)
Assessment of Quality of Life Instrument (AQoL II)
12-item Short Form Health Survey (SF-12)
Arthritis Self-Efficacy Questionnaire
Illness Perception Questionnaire Revised (IPQ-R)
Medical Outcomes Study (MOS) Social Support Survey
9-item Patient Health Questionnaire (PHQ-9)
Revised Health Hardiness Inventory
Physical Activity Scale for the Elderly (PASE)
Log book (retrospectively for prior 4 weeks)
Open-ended questioning (12 weeks)
General practitioner treatment records (12 weeks)
ated.
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past week as secondary outcomes. Pain is also assessed,
along with physical function, using the disease-specific
WOMAC Osteoarthritis Index [31]. The physical func-
tion subscale, which comprises 17 questions, is the pri-
mary outcome measure for self-reported physical
function. A secondary measure of physical function is a
NRS assessing average restriction to daily activities over
the past week with terminal descriptors of “no restric-
tion” and “maximum restriction possible”.
At the 12 week and 12 month assessments, partici-
pants rate their perceived change in a) pain; b) physical
function and; c) overall, compared to baseline on a five-
point ordinal scale (1-much worse to 5-much better).
Scales of this kind are frequently used as an external cri-
terion for comparison with changes in scores of other
outcomes [32]. Measuring participant-perceived change
using a rating of change scale has been shown to be a
clinically relevant and stable concept for interpreting
truly meaningful improvements from the individual per-
spective [33].
Health-related quality of life
Health-related quality of life is measured using the As-
sessment of Quality of Life instrument version two
(AQoL II). The AQoL II has 20 questions that cover six
dimensions of health-related quality of life including in-
dependent living, social relationships, physical senses,
coping, pain and psychological wellbeing. The AQoL has
strong psychometric properties and is more responsive
than other more widely used scales [34,35]. It produces
a single utility index that ranges from −0.04 (worst pos-
sible health-related quality of life) to 1.00 (full health-
related quality of life).
The 12-item Short Form Health Survey (SF-12) is also
being used to measure health-related quality of life [36].
The SF-12 is a self-administered questionnaire that was
designed to measure patient outcomes in medical prac-
tice and clinical research and to evaluate the effective-
ness of health interventions. The 12 questions in the
SF-12 measure an individual’s perceived health across
eight domains: physical functioning; role limitations be-
cause of physical health problems; bodily pain; general
health perceptions; energy/fatigue; social functioning;
role limitations because of emotional problems; and gen-
eral mental health. The SF-12 is scored so that a high
score indicates better functioning. Scoring algorithms
are applied to individual item responses to produce the
composite Physical Component Summary (PCS) and
Mental Component Summary (MCS) scores. The PCS
and MCS scores have a range of 0 to 100 and were
designed to have a mean score of 50 and a standard de-
viation of 10; scores greater than 50 represent above
average health status.Psychosocial measures
A range of psychosocial measures are being collected in
order to evaluate whether psychosocial parameters are
associated with changes in pain, physical function and
health-related quality of life observed with acupuncture.
i) Arthritis Self-Efficacy Scale is used to measure self-
efficacy. It has three subscales that assess self-efficacy
for control of pain management (5 questions),
physical function (9 questions) and other arthritis
symptoms (6 questions). Each question is rated on a
10-point NRS from 1 (“very uncertain”) to 10
(“very certain”). Prior studies have supported both
the reliability and validity of this scale [37].
ii) Illness Perception Questionnaire Revised (IPQ-R) is
used to measure participant’s perceptions of their
arthritis [38]. It comprises 38 items, each rated on a
5-point Likert scale, ranging from “strongly disagree”
to “strongly agree”. The IPQ-R assesses numerous
dimensions including identity, timeline acute/
chronic, timeline cyclical, consequences, personal
control, treatment control, illness coherence,
emotional representations. It has demonstrated
reliability and validity [38].
iii)Medical Outcomes Study (MOS) Social Support
Survey is used to measure the perceived social
support available to an individual. It comprises six
questions that ask respondents to indicate how often
each of six different types of support is available to
them. Responses are scored on a five-point scale
ranging from “all of the time” to “none of the time”.
This measure of social support has been shown to
have adequate validity and reliability [39].
iv)Patient Health Questionnaire (PHQ) is a self-
administered version of the PRIME-MD diagnostic
instrument for common mental disorders [40] . This
trial is utilizing the PHQ-9 [41], which is the
depression module that scores each of the 9 DSM-IV
criteria [42] as “0” (not at all) to “3” (nearly every
day).
v) Revised Health Hardiness Inventory comprises 24
items and is used to measure health hardiness
(control, commitment, and challenge) in individuals
with actual health problems. Respondents indicate
on a 5-point scale the degree to which they agree
with the statement, ranging from “strongly disagree”
to “strongly agree”. This questionnaire has adequate
psychometric properties, and is a reliable and useful
instrument to assess perspectives towards one’s own
health [43].
Physical activity levels
Habitual physical activity is measured using the Physical
Activity Scale for the Elderly (PASE), a self-report
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and sensitive to change in people with knee OA [44,45].
It records both the level and type of recreational and oc-
cupational physical activity undertaken by participants
over the previous week. The PASE was developed and
validated in samples of older adults (age 55+ years) [46].
Use of health care, home assistance and work absences
Information on health care use (e.g. visits to hospitals,
medical practitioners, other health professionals, use
of investigative procedures, prescription and non-
prescription drugs) and the need for paid and/or unpaid
home assistance over the previous four weeks will be
collected via a log-book at baseline, 12 weeks and
12 months. Participants are also asked to record any
absences from paid employment (if applicable) and/or
unpaid work (eg household duties, caring for family/
friends) because of their health. The log-book utilises a
checklist format to minimize respondent burden and to
ensure high quality data is obtained with minimal data
loss.
Adverse events
Adverse events were monitored via open-ended ques-
tioning by the acupuncturist at each treatment session
and recorded in the treatment notes. In addition, partici-
pants receiving acupuncture treatment were asked at
12 weeks whether they experienced any adverse effects
of treatment via open-ended questioning.
Treatment session attendance
Participant adherence was measured by recording the
number of treatment sessions attended (out of a max-
imum number of 12) in the GP treatment notes.
Sample size calculations
Our primary endpoints are average overall knee pain
measured on a NRS and physical function measured via
WOMAC at 12 weeks. The minimum clinically import-
ant difference to be detected in OA trials is a change in
pain of 1.8 units (on NRS) [47] and a change of 6 phys-
ical function units on the WOMAC (out of 68) [48].
Calculations are based on an analysis of covariance
(ANCOVA) adjusting for baseline of the outcome vari-
able, and assume a between-patient standard deviation
of 3.0 units for pain and 12.0 units for WOMAC [49].
Sample size calculations for our particular study design
need to take into account four aspects: clustering effects
resulting from treatment of patients by the same therap-
ist for comparisons with the control arm (hypothesis
H2); dilution of the treatment effect resulting from the
Zelen design [50]; precision gain from baseline adjust-
ment; and loss to followup. Initially assuming no cluster-
ing effects and a regular two-arm parallel RCT designwith complete followup, 33 patients per arm would be
required to detect the above differences in pain and
function with 80% power at a two-sided 5% significance
level, using ANCOVA with assumed baseline to 12 week
correlations of 0.50 for pain and 0.70 for function [49].
Adopting a conservative intra-therapist correlation of
0.10 inflates the sample size to 40 patients per arm
across a total of 10 therapists. Assuming a conservative
15% non-consent rate for patients randomised to any of
the three treatment arms increases the sample size by 1/
(1–0.15)2 = 38%, and finally, allowing for 15% loss to fol-
lowup, inflates the total sample size to 66 patients per
arm, which we round up to 70 per arm, or 280 patients
in total. Assessment of hypotheses H1 and H3 involve
within-therapist comparisons only and therefore the pre-
cision loss from clustering by therapist does not apply,
yielding greater power (90%) for these comparisons.
Statistical analyses
The primary analysis of the data will be undertaken
using the principle of intention-to-treat with all rando-
mised patients included in the analyses. Demographic
and clinical characteristics, as well as baseline data, will
be presented to assess the baseline comparability of the
intervention groups. Descriptive statistics will be pre-
sented for each group as the mean change (standard de-
viation, 95% confidence intervals) in the outcomes from
baseline to each time point. Differences in mean change
from baseline to each time point will be compared be-
tween groups using random effects linear regression
modelling adjusting for baseline levels of the outcome
measure and using the treating therapists as random
effects to account for clustering of outcomes by thera-
pists. Model assumptions will be checked by standard
diagnostic plots. Improvement between acupuncture
groups (based on the perceived ratings of change) will
be compared using logistic regression with random
effects as above and presented as odds ratios with 95%
confidence intervals. Multiple imputation methodology
will be employed to account for missing data [51]. No
statistical adjustment will be made for multiple testing.
All tests will be two sided and carried out at the 5% level
of significance.
As part of the secondary analyses of the primary out-
comes at 12 weeks and 12 months, we plan to conduct a
separate analysis to estimate the effect of treatment in
the hypothetical scenario of full adherence to the rando-
mised treatment intervention. Analytical methods for
this will utilise instrumental variables methodology in-
volving two stage least squares estimation [52].
Economic evaluation
The economic evaluation will be conducted from the
perspective of the Australian health care system and the
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ation alongside a clinical trial will be used to evaluate
the differences in resource use and health outcomes at
the end of treatment and at 12 months. The primary
economic evaluation will take the form of a cost effect-
iveness study with a range of outcome measures includ-
ing the incremental cost per extra person with a
clinically significant improvement in pain and function
and per extra quality adjusted life years (QALYs) for
laser acupuncture compared to either sham or needle
acupuncture. The difference in QALYs will be calculated
in the primary analysis as the difference in the area
under the curve for AQoL scores over the duration of
12 months. Differences in mean change from baseline
for the AQoL to each time point will be weighted by the
time from baseline using generalised linear regression
modelling adjusting for baseline levels of the AQoL to
construct QALYs, and then compared between groups.
Differences in the mean cost between groups will be cal-
culated using generalised linear regression modelling. In-
cremental cost per QALY will be calculated as the ratio
of the difference in mean cost to the difference in mean
QALYs with 95% confidence intervals calculated using
Fieller's theorem.
Timelines
The application for project funding was successful in
December 2008 and funding commenced in August
2009. Ethics approval was obtained from the Human Re-
search Ethics Committee of the University of Melbourne
in July 2009. Recruitment commenced in February 2010
and was completed in December 2011. The trial is due
for completion in December 2012 when all participants
will have completed 12-month follow-up.
Discussion
This paper has presented the theoretical rationale, as
well as the protocol, for an ongoing Zelen design RCT
that is testing the efficacy of a combined Western and
Traditional Chinese Medicine style of acupuncture for
managing chronic knee pain and disability symptoms in
older people. The findings of this study will help deter-
mine whether laser and/or needle acupuncture are effi-
cacious in relieving knee pain and/or improving physical
function. This study will also determine whether effects
of acupuncture can be maintained over the longer term,
and whether psychosocial factors influence treatment
outcomes. Importantly, the use of the Zelen design will
minimize the bias typically encountered in traditionally
designed RCTs where participant expectations may in-
fluence study outcomes.
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